A5085672628- Urinary Bladder and Prostate Research
- Prostate Cancer Diagnosis and Treatment
- Pelvic floor disorders treatments
- Hormonal and reproductive studies
- Urological Disorders and Treatments
- Sexual function and dysfunction studies
- Urinary Tract Infections Management
- Urologic and reproductive health conditions
- Cancer survivorship and care
- Genital Health and Disease
- Pediatric Urology and Nephrology Studies
- Bladder and Urothelial Cancer Treatments
- Anorectal Disease Treatments and Outcomes
- Cardiovascular Syncope and Autonomic Disorders
- Prostate Cancer Treatment and Research
- Anesthesia and Pain Management
- Cardiac, Anesthesia and Surgical Outcomes
- Ureteral procedures and complications
- Sexual Differentiation and Disorders
- Kidney Stones and Urolithiasis Treatments
- Diverticular Disease and Complications
- Health Systems, Economic Evaluations, Quality of Life
- Gastroesophageal reflux and treatments
- Climate Change and Health Impacts
- Botulinum Toxin and Related Neurological Disorders
University of Toronto
2016-2025
University Health Network
2016-2025
Toronto Western Hospital
2013-2025
Princess Margaret Cancer Centre
2010-2024
Université de Montréal
2022-2024
Centre Hospitalier de l’Université de Montréal
2024
Cornell University
2012-2023
Southwestern Medical Center
2023
Health Net
2019-2023
Presbyterian Hospital
2012-2023
Objective: To assess the degree of psychological impact among surgical providers during COVID-19 pandemic. Summary Background Data: The pandemic has extensively impacted global healthcare systems. We hypothesized that would be higher for deployed work, certain specialties, and those who knew someone diagnosed with, or died, COVID-19. Methods: conducted a web-based survey to investigate primary outcomes were depression anxiety stress scale-21 Impact Event Scale-Revised scores. Results: A...
We report 5-year safety and efficacy outcomes of the Aquablation procedure for treatment men with symptomatic benign prostatic hyperplasia large-volume prostate glands.A total 101 moderate to severe symptoms volumes between 80 150 mL underwent a robotic-assisted in prospective multicenter international trial (NCT03123250). Herein we final results.The study successfully met its performance goal, which was based upon transurethral resection typically done smaller prostates, at 3 months. Mean...
Abstract Background ChatGPT has recently emerged as a novel resource for patients’ disease-specific inquiries. There is, however, limited evidence assessing the quality of information. We evaluated accuracy and ChatGPT’s responses on male lower urinary tract symptoms (LUTS) suggestive benign prostate enlargement (BPE) when compared to two reference resources. Methods Using patient information websites from European Association Urology American Urological material, we formulated 88...
To evaluate postoperative outcomes after a minimal approach of water vapor thermal therapy (WVTT; Rezum, Boston Scientific, Marlborough, MA, USA), defined as 1 treatment per prostate lobe, among men with benign prostatic hyperplasia (BPH). We performed multi-institutional retrospective review patients who underwent WVTT from 2018 to 2022. Propensity score matching (PSM) was utilized generate patient cohorts based on number treatments lobe (1 including median if present [minimal group], vs ≥2...
MLUTS secondary to BPH remains one of the most common age-related disorders afflicting men. As aging Canadian population continues, more men will be seeking advice and looking for guidance from their healthcare providers on management symptoms. The information offered in this guideline document, based consensus evaluation best available evidence, aid urologists as they strive provide state-of-the-art care patients.
To present early safety and feasibility data from a multicentre prospective study (WATER II) of aquablation in the treatment symptomatic men with large-volume benign prostatic hyperplasia (BPH).Between September December 2017, 101 moderate-to-severe BPH symptoms prostate volume 80-150 mL underwent international clinical trial. Baseline demographics standardized postoperative management variables were carefully recorded central independently monitored database. Surgeons answered analogue...
Background: Sexual dysfunction in people with cancer is a significant problem. The present clinical practice guideline makes recommendations to improve sexual function cancer. Methods: This was undertaken by the Interventions Address Problems People Cancer Expert Panel, group organized Program Evidence-Based Care (PEBC). Consistent PEBC standardized approach, systematic search conducted for existing guidelines, and literature MEDLINE EMBASE years 2003–2015 systematically searched both...
To evaluate the efficacy and safety of Rezūm therapy in benign prostatic hyperplasia (BPH) patients with prostates ≥80 mL.A prospective registry was established at two high-volume Canadian centres. Patients had baseline medical history documented, uroflowmetry questionnaire results were recorded over 12 months.Eighty-three (median [interquartile range {IQR}] age 69.2 [63.2, 74.8] years) a prostate size mL included. The median (IQR) volume 100.0 (88.5, 115.0) 65% lobe. Twenty-one prior...
To evaluate outcomes after laser endoscopic enucleation of the prostate (EEP) stratified by whether early apical release (EAR) was performed or not.
Abstracts submitted to medical meetings do not undergo the same critical peer review process as published manuscripts. Despite this limited scrutiny presented abstracts often influence clinical thinking and practice. Consequently reviewed publication rate of becomes in judging quality research. We determined factors influencing it.All 1,584 at 2000 American Urological Association Annual Meeting were assessed for subsequent with a fixed MEDLINE search protocol. searched publications from...
To present 6-month safety and effectiveness data from a multicentre prospective study of aquablation in men with lower urinary tract symptoms (LUTS) attributable to benign prostatic hyperplasia (BPH) prostate volumes between 80 150 mL.Between September December 2017, 101 LUTSattributable BPHwere prospectively enrolled at 16 centres Canada the USA.The mean volume was 107 mL. The length hospital stay after procedure 1.6 days (range: same day 6 days). primary endpoint (Clavien-Dindo grade 2 or...
To report 12-month safety and effectiveness outcomes of the Aquablation procedure for treatment men with symptomatic benign prostatic hyperplasia (BPH) large-volume prostates.One hundred one moderate-to-severe BPH symptoms prostate volumes 80-150 cc underwent a robotic-assisted in prospective multicenter international clinical trial. Functional were assessed at 12 months postoperatively.Mean volume was 107 (range 80-150). Mean operative time 37 minutes mean resection 8 minutes. The average...
The Optilume BPH Catheter System is a novel drug/device combination minimally invasive surgical therapy for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. PINNACLE study prospective, randomized, double-blind, sham-controlled clinical trial evaluating safety and efficacy against sham procedure.
Up to 50% of men over 50 and 80% 80 are affected by BPH. Shared decision-making regarding BPH treatment options can benefit from an improved understanding relative risks benefits for various treatments.